XTX Topco’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

XTX Topco’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,022	Closed	-$41.4K	–	2642
2024 Q1	$41.4K	Sell	26,022 -2,954	-10%	-$4.38K	0.01%	1504
2023 Q4	$24.9K	Sell	28,976 -6,639	-19%	-$5.83K	0.01%	1338
2023 Q3	$38.1K	Sell	35,615 -7,830	-18%	-$16.2K	0.01%	1307
2023 Q2	$113K	Sell	43,445 -18,067	-29%	-$64.5K	0.02%	1150
2023 Q1	$251K	Buy	+61,512	New	+$284K	0.05%	791
2022 Q3	–	Sell	-34,571	Closed	-$443K	–	1455
2022 Q2	$443K	Buy	+34,571	New	+$479K	0.18%	144

XTX Topco's NGM Position: Q2 2024 in Review

XTX Topco sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 26,022 shares — an estimated $41.4K sold.

XTX Topco first reported a position in NGM in Q2 2022 and held it in 6 quarters. The position peaked at $443K in Q2 2022. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

XTX Topco reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
XTX Topco sold 26,022 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $41.4K.
XTX Topco first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
XTX Topco's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $443K in Q2 2022.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.